University of Southern California (USC) Radioactive Drug Research Committee #36, Los Angeles, CA – FDA Inspections
Inspection records and compliance data for University of Southern California (USC) Radioactive Drug Research Committee #36 in Los Angeles, California. 1 FDA inspection on record, 1 Form 483, last inspected July 25, 2018.
This profile covers University of Southern California (USC) Radioactive Drug Research Committee #36 based in Los Angeles, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
Inspected July 25, 2018.
Most cited issue areas
- Annual reports not submitted to FDA1 inspection
- RDRC has not kept minutes of its meetings1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 25, 2018 | VAI | Human Drugs · Bioresearch Monitoring | 1059930 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
University of Southern California (USC) Radioactive Drug Research Committee #36
FEI Number
3014498529
Address
2250 Alcazar Street, Csc 103, Director, Usc Molecular Imaging Center, Los Angeles, California 90033, United States
Country
United States
ID: 83e72b0c-dcf8-4b05-a1c1-98084267bc03